Nicole Lamanna
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia (NCT03609593) | Nicole Lamanna | 2018-11-12 |
Track Nicole Lamanna automatically
Every clearance here is in the API, with alerts when new ones post.